Domperidone in the management of symptoms of diabetic gastroparesis: efficacy, tolerability, and quality-of-life outcomes in a multicenter controlled trial

David Silvers(Universal Sensors (United States)), Alan F. Joslyn(Janssen (United States)), Yin Liu(Janssen (United States)), Eamonn M.M. Quigley(Hagley Museum and Library), Christina Farup(Janssen (United States)), Mark Kipnes(Diabetes & Glandular Disease Clinic), Vasti L. Broadstone(University of Louisville Hospital), Richard W. McCallum(University of Kansas), Nancy Kline Leidy(Ithaka Harbors), David Patterson(Virginia Mason Medical Center)
Clinical Therapeutics
May 1, 1998
10.1016/s0149-2918(98)80054-4
Cited by 146

Related Papers

Development and first validation of the COPD Assessment Test
|European Respiratory Journal|2009|3.2k
Worldwide Prevalence and Burden of Functional Gastrointestinal Disorders, Results of Rome Foundation Global Study
|Gastroenterology|2020|2.1k
Content Validity—Establishing and Reporting the Evidence in Newly Developed Patient-Reported Outcomes (PRO) Instruments for Medical Product Evaluation: ISPOR PRO Good Research Practices Task Force Report: Part 2—Assessing Respondent Understanding
|Value in Health|2011|1.1k
Content Validity—Establishing and Reporting the Evidence in Newly Developed Patient-Reported Outcomes (PRO) Instruments for Medical Product Evaluation: ISPOR PRO Good Research Practices Task Force Report: Part 1—Eliciting Concepts for a New PRO Instrument
|Value in Health|2011|1.1k
Irritable bowel syndrome
|Nature Reviews Disease Primers|2016|981